Page last updated: 2024-08-23

paclitaxel and Atypical Endometrial Hyperplasia

paclitaxel has been researched along with Atypical Endometrial Hyperplasia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Che, YC; Li, X; Pan, XY; Zhang, Y1
Wang, HJ; Zheng, WX1

Reviews

1 review(s) available for paclitaxel and Atypical Endometrial Hyperplasia

ArticleYear
[Precursor lesions of type II endometrial cancer: diagnostic criteria and pathogenesis].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2007, Volume: 36, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma in Situ; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Paclitaxel; Precancerous Conditions; Radiotherapy, Adjuvant; Uterine Neoplasms

2007

Other Studies

1 other study(ies) available for paclitaxel and Atypical Endometrial Hyperplasia

ArticleYear
[Study of claudin-4 in the diagnosis and treatment of endometrial carcinoma].
    Zhonghua fu chan ke za zhi, 2013, Volume: 48, Issue:10

    Topics: Animals; Cell Line, Tumor; Cisplatin; Claudin-4; Disease Models, Animal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Real-Time Polymerase Chain Reaction; RNA, Messenger; Transplantation, Heterologous

2013